Abstract

Simple SummaryAdipose stromal vascular fraction (SVF) cells are freshly isolated non-cultured mesenchymal stem cells, which have been recently applied in the treatment of several musculoskeletal inflammatory conditions in dogs. However, the best adipose tissue (AT) sampling site is still challenging. This study first addressed the ideal AT harvesting site in canines ranging between middle and old age, the most susceptible age to chronic musculoskeletal problems. Our results showed that the peri-ovarian region is the best AT harvesting site, which yields high amounts of SVF cells with enough adipose-derived stem cells. These data may help the further set-up of cell-based regenerative therapies at the preclinical and experimental level in canines.Mesenchymal stem cells (MSCs) constitute a great promise for regenerative therapy, but these cells are difficultly recovered in large amounts. A potent alternative is the stromal vascular fraction (SVF), non-cultured MSCs, separated from adipose tissue (AT). We aim to evaluate AT harvesting site effect on the SVF cells’ quantity and quality in dogs. Subcutaneous abdominal fat, falciform ligament and peri-ovarian fat were sampled. After SVF isolation, the trypan blue exclusion test and a hemocytometer were used to assess the cell viability and cellular yield. SVF cells were labeled for four surface antigenic markers, clusters of differentiation CD90, CD44, CD29, and CD45, and then examined by flow cytometry. Semi-quantitative RT-PCR was used to evaluate the gene expression of the former markers in addition to OCT-4 and CD34. SVF cells in the peri-ovarian AT recorded the highest viability% (99.63 ± 0.2%), as well as a significantly higher cellular yield (36.87 ± 19.6 × 106 viable cells/gm fat, p < 0.001) and a higher expression of adipose-derived mesenchymal stem cells AD-MSCs surface markers than that of other sites. SVF cells from the peri-ovarian site revealed a higher expression of MSC markers (CD90, CD44, and CD29) and OCT-4 compared to the other sites, with weak CD45 and CD34 expressions. The positive OCT-4 expression demonstrated the pluripotency of SVF cells isolated from different sites. To conclude, the harvesting site is a strong determinant of SVF cells’ quantity and quality, and the peri-ovarian site could be the best AT sampling site in dogs.

Highlights

  • The use of mesenchymal stem cells (MSCs) in regenerative medicine holds a great promise for repairing damaged tissues in both acute conditions, such as injuries of ligaments, tendons, cartilage or bone, and chronic conditions, such as osteoarthritis [1]

  • Stromal vascular fraction (SVF) cells can be directly separated from minced Adipose tissue (AT) tissue by incubation with collagenase enzyme followed by centrifugation [7,8]

  • We could not define SVF cells with multiple MSC marker criteria due to the lack of suitable facilities, our results showed that the isolated SVF from different sites expressed AD-MSC surface markers (CD90, CD44, and CD29) and lacked the CD45 hematopoietic stem cell marker

Read more

Summary

Introduction

The use of mesenchymal stem cells (MSCs) in regenerative medicine holds a great promise for repairing damaged tissues in both acute conditions, such as injuries of ligaments, tendons, cartilage or bone, and chronic conditions, such as osteoarthritis [1]. These cells have been separated from many tissues, including bone marrow, adipose tissue, blood, cartilage, and muscle [2]. SVF cells are a heterogeneous cell population from adipose stromal cells, progenitor cells, hematopoietic stem cells, and endothelial cells This cell population produces a homogeneous cell population of plastic adherent AD-MSCs when expanded on culture [9]. Primary SVF and cultured AD-MSCs, represent an important therapeutic target [10]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call